heptakis(2,6-o-dimethyl)beta-cyclodextrin has been researched along with dalteparin in 1 studies
| Studies (heptakis(2,6-o-dimethyl)beta-cyclodextrin) | Trials (heptakis(2,6-o-dimethyl)beta-cyclodextrin) | Recent Studies (post-2010) (heptakis(2,6-o-dimethyl)beta-cyclodextrin) | Studies (dalteparin) | Trials (dalteparin) | Recent Studies (post-2010) (dalteparin) |
|---|---|---|---|---|---|
| 148 | 0 | 45 | 5,665 | 1,423 | 2,267 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahsan, F; Bai, S; Mustafa, F; Yang, T | 1 |
1 other study(ies) available for heptakis(2,6-o-dimethyl)beta-cyclodextrin and dalteparin
| Article | Year |
|---|---|
Pulmonary delivery of low molecular weight heparins.
Topics: Animals; Anticoagulants; beta-Cyclodextrins; Biological Transport, Active; Bronchi; Cell Line; Chemistry, Pharmaceutical; Dalteparin; Dose-Response Relationship, Drug; Drug Delivery Systems; Electric Conductivity; Enoxaparin; Epithelial Cells; Factor Xa; Heparin, Low-Molecular-Weight; Humans; Lung; Male; Maltose; Rats; Rats, Sprague-Dawley; United States | 2004 |